BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.00699
0.00 (0.00%)
At close: Aug 7, 2026
BioRegenx Market Cap
BioRegenx has a market cap or net worth of $6.79 million as of August 10, 2026. Its market cap has decreased by -60.71% in one year.
Market Cap
6.79M
Enterprise Value
8.91M
Revenue
1.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
ChartMarket Cap Chart
Since March 12, 2024, BioRegenx's market cap has decreased from 49.89M to 6.79M, a decrease of -86.39%. That is a compound annual growth rate of -56.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 6.79M | -45.27% |
| Dec 31, 2025 | 12.41M | 44.15% |
| Dec 31, 2024 | 8.61M | -82.74% |
| Mar 12, 2024 | 49.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Healixa | 28.45M |
| Pharma-Bio Serv | 13.28M |
| PreAxia Health Care Payment Systems | 9.47M |
| CompuMed | 7.95M |
| Vynleads | 7.51M |
| DATATRAK International | 7.08M |
| Resilient Healthcare | 3.31M |
| StrainsforPains | 2.71M |